263 related articles for article (PubMed ID: 14984958)
1. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
[TBL] [Abstract][Full Text] [Related]
2. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
4. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter].
Song Y; Kong BH; Liu PS; Ma DX; Qu X; Jiang S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):438-42. PubMed ID: 12974091
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
7. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific expression detected with the use of an expression vector driven by human telomerase reverse transcriptase gene promoter.
Yin J; Fu P; Wang X; Jin G; Xiu R
J Lab Clin Med; 2004 Dec; 144(6):302-6. PubMed ID: 15614252
[TBL] [Abstract][Full Text] [Related]
9. [Study on cloning of hTERT promoter and its targeting transcriptional activities in telomerase-positive lung cancer cells].
Wang YP; Tang XJ; Chen XH; Che GW; Zhu DX; Sun ZL; Zhou QH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):497-501. PubMed ID: 16909587
[TBL] [Abstract][Full Text] [Related]
10. Targeted gene therapy of ovarian cancer using an ovarian-specific promoter.
Bao R; Selvakumaran M; Hamilton TC
Gynecol Oncol; 2002 Feb; 84(2):228-34. PubMed ID: 11812079
[TBL] [Abstract][Full Text] [Related]
11. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.
Casado E; Gomez-Navarro J; Yamamoto M; Adachi Y; Coolidge CJ; Arafat WO; Barker SD; Wang MH; Mahasreshti PJ; Hemminki A; Gonzalez-Baron M; Barnes MN; Pustilnik TB; Siegal GP; Alvarez RD; Curiel DT
Clin Cancer Res; 2001 Aug; 7(8):2496-504. PubMed ID: 11489832
[TBL] [Abstract][Full Text] [Related]
12. Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.
Bilsland AE; Anderson CJ; Fletcher-Monaghan AJ; McGregor F; Evans TR; Ganly I; Knox RJ; Plumb JA; Keith WN
Oncogene; 2003 Jan; 22(3):370-80. PubMed ID: 12545158
[TBL] [Abstract][Full Text] [Related]
13. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
[TBL] [Abstract][Full Text] [Related]
14. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
[TBL] [Abstract][Full Text] [Related]
15. Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells.
Tanyi JL; Lapushin R; Eder A; Auersperg N; Tabassam FH; Roth JA; Gu J; Fang B; Mills GB; Wolf J
Gynecol Oncol; 2002 Jun; 85(3):451-8. PubMed ID: 12051873
[TBL] [Abstract][Full Text] [Related]
16. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
18. [Construction of an expression vector under the control of hTERT promoter].
Han MK; Zhang HZ; Cheng SY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):384-6. PubMed ID: 15862165
[TBL] [Abstract][Full Text] [Related]
19. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
20. [Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy].
Li F; Tan XH; Peng XJ; Cai HB; Hu DR
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):207-11. PubMed ID: 15699008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
